

































































Comment on “Comparison of analgesic
efficacy between rectus sheath blockade,
intrathecal morphine with bupivacaine, and
intravenous patient-controlled analgesia in
patients undergoing robot-assisted
laparoscopic prostatectomy: a prospective,
observational clinical study”
Lukas M. Löffel* , Dominique Engel and Patrick Y. Wuethrich
Dear Editor.
We read with great interest the article “Comparison of
analgesic efficacy between rectus sheath blockade, intra-
thecal morphine with bupivacaine, and intravenous
patient-controlled analgesia in patients undergoing
robot-assisted laparoscopic prostatectomy: a prospective,
observational clinical study” by Shim et al. [1] Yet we
think that there are relevant methodological issues and
therefore we raise concerns about the potential for
generalization of the results for other centers.
The observational nature of the trial with patients be-
ing able to choose their analgesic regimen themselves
poses a significant risk of bias. The patients opting for
intrathecal analgesia may be different in their general
perception of pain and satisfaction compared to the
other groups. According to the flowchart, only 103 pa-
tients had to be evaluated for inclusion, of which 13
dropped out because of fulfilling the exclusion criteria.
In our experience, it seems unlikely that the remaining
90 participants could be distributed exactly equal to
three groups of 30 the trial aimed for, even though they
were reported to be able to choose themselves unre-
strictedly. The authors state that there were no adverse
events such as respiratory depression, which is a well
known complication of intrathecal morphine [2]. This
occurs with a delay of up to 24 h postoperatively. How
were patients monitored for this complication? Further-
more, it is not clear how the sample size analysis was
performed. Shim et al. state that it was based on drug
consumption of 20 patients on postoperative day 1.
There is uncertainty how these patients were identified.
Last but not least, the reviewers of this paper also raised
concerns that the study is not comprehensive and that
the conclusions cannot be sufficiently supported [3].
With our ongoing three-arm randomized controlled
trial “Impact of Perioperative Analgesia in Prostatectomy
Patients on Early Quality of Recovery” (“SPITALIDO”,
registered on clinicaltrials.gov on August 7, 2018 with
the identifier NCT03618693) we hope to omit these
methodological issues and to provide further data for
the studied patient population [4].
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